Institutional Ownership Sana Biotechnology, Inc. (SANA)
This table provides information about the institutional ownership of Sana Biotechnology, Inc. (SANA). We have compiled data on the 178 institutions that hold shares in the stock, with a total of 122 Million shares, which have been reported (via 13F filing form) to have a value of $376 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Flagship Pioneering Inc.
Cambridge, MA |
Feb 14, 2025 Q4 2024 |
25,001,856
shares
|
$76.5 Million
12.19% of portfolio
|
Q4 2023
Reduced 24.9%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
11,045,448
shares
|
$33.8 Million
0.0% of portfolio
|
Q2 2024
Added 22.1%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
10,747,760
shares
|
$32.9 Million
0.0% of portfolio
|
Q4 2024
Reduced 18.48%
|
|
Baillie Gifford & CO
|
Jan 31, 2025 Q4 2024 |
10,233,573
shares
|
$31.3 Million
0.01% of portfolio
|
Q4 2024
Reduced 0.43%
|
|
Canada Pension Plan Investment Board
Toronto Ontario, A6 |
Feb 13, 2025 Q4 2024 |
10,175,000
shares
|
$31.1 Million
0.02% of portfolio
|
Q1 2021
New holding
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
6,709,661
shares
|
$20.5 Million
0.0% of portfolio
|
Q4 2024
Added 1.24%
|
|
Capital World Investors
Los Angeles, CA |
Feb 13, 2025 Q4 2024 |
5,449,035
shares
|
$16.7 Million
0.0% of portfolio
|
Q1 2024
Added 255.84%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
3,193,081
shares
|
$9.77 Million
0.0% of portfolio
|
Q4 2024
Added 0.84%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
3,108,617
shares
|
$9.51 Million
0.0% of portfolio
|
Q4 2024
Added 7.6%
|
|
Crestline Management, LP
Fort Worth, TX |
Feb 13, 2025 Q4 2024 |
2,860,937
shares
|
$8.75 Million
0.16% of portfolio
|
Q4 2024
Reduced 7.28%
|
|
Alphabet Inc.
Mountain View, CA |
Feb 06, 2025 Q4 2024 |
2,812,500
shares
|
$8.61 Million
0.32% of portfolio
|
Q1 2021
New holding
|
|
Baker Bros. Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
2,380,949
shares
|
$7.29 Million
0.04% of portfolio
|
Q1 2024
Added 19.05%
|
|
Integral Health Asset Management, LLC
|
Feb 14, 2025 Q4 2024 |
2,000,000
shares
|
$6.12 Million
0.29% of portfolio
|
Q4 2024
Added 11.11%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,910,219
shares
|
$5.85 Million
0.0% of portfolio
|
Q4 2024
Added 0.38%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
1,557,496
shares
|
$4.77 Million
0.0% of portfolio
|
Q4 2024
Added 44.36%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
1,205,537
shares
|
$3.69 Million
0.0% of portfolio
|
Q4 2024
Added 572.38%
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,188,346
shares
|
$3.64 Million
0.0% of portfolio
|
Q4 2024
Added 5.32%
|
|
Ci Private Wealth, LLC
Miami, FL |
Feb 10, 2025 Q4 2024 |
1,182,699
shares
|
$3.62 Million
0.0% of portfolio
|
Q4 2024
Added 161.66%
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
1,131,813
shares
|
$3.46 Million
0.0% of portfolio
|
Q4 2024
Added 11.35%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
1,056,512
shares
|
$3.23 Million
0.0% of portfolio
|
Q4 2024
Added 0.83%
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
1,004,651
shares
|
$3.07 Million
0.0% of portfolio
|
Q4 2024
Added 18.19%
|
|
Omega Fund Management, LLC
Boston, MA |
Feb 14, 2025 Q4 2024 |
843,750
shares
|
$2.58 Million
2.1% of portfolio
|
Q2 2021
New holding
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
806,635
shares
|
$2.47 Million
0.0% of portfolio
|
Q4 2024
Reduced 12.05%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
728,901
shares
|
$2.23 Million
0.0% of portfolio
|
Q4 2024
Added 1264.47%
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
690,141
shares
|
$2.11 Million
0.01% of portfolio
|
Q4 2024
Added 0.34%
|